Treos Revenue and Competitors
Estimated Revenue & Valuation
- Treos's estimated annual revenue is currently $2.6M per year.
- Treos's estimated revenue per employee is $155,000
Employee Data
- Treos has 17 Employees.
- Treos grew their employee count by 0% last year.
Treos's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Bioinformatics | Reveal Email/Phone |
2 | Investor Director and Chief Financial Officer | Reveal Email/Phone |
3 | CHIEF LEGAL OFFICER | Reveal Email/Phone |
4 | CHIEF SCIENTIFIC OFFICER | Reveal Email/Phone |
Treos Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.5M | 29 | -12% | N/A | N/A |
#2 | $15.7M | 101 | 5% | N/A | N/A |
#3 | $87.9M | 405 | 25% | $292M | N/A |
#4 | $2.6M | 470 | 16% | $631.7M | N/A |
#5 | $14.9M | 96 | -8% | $81M | N/A |
#6 | $44.8M | 231 | 0% | $132.9M | N/A |
#7 | $7.6M | 49 | -37% | N/A | N/A |
#8 | $17.4M | 112 | 12% | N/A | N/A |
#9 | $334.6M | 1349 | 11% | £994.6M | N/A |
#10 | $830.2M | 5356 | 8% | N/A | N/A |
What Is Treos?
At TREOS we use our cancer vaccine technology to develop precision cancer immunotherapies. These therapies are peptide vaccines that induce potent immune responses to kill the specific cancer cells in patients predicted by our diagnostic tests to respond.
keywords:N/A
N/A
Total Funding
17
Number of Employees
$2.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Treos News
2022-03-30 - Significant Rare Earth Element (REE) Results Identified at Batemans Project
Over 420 pXRF samples returned Total Rare Earth Oxide (TREO) results ... The plotted analytical results for the TREOs revealed significant...
Other Companies in LONDON
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.5M | 17 | -11% | N/A |
#2 | $1.3M | 17 | N/A | $8M |
#3 | $1.5M | 17 | 0% | N/A |
#4 | $1.5M | 17 | -41% | N/A |
#5 | $2.2M | 17 | -6% | N/A |